# Antiplatelet Strategy for CCS Patients Undergoing CABG

> **NCT06881901** · — · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 29898 (actual)

## Conditions studied

- Chronic Coronary Syndrome
- Coronary Artery Bypass Graft CABG

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06881901
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 29898 (ACTUAL)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06881901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06881901, "Antiplatelet Strategy for CCS Patients Undergoing CABG". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06881901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*